Renata PLC (DSE:RENATA)
424.40
-1.70 (-0.40%)
At close: Nov 12, 2026
Renata Revenue
Renata had revenue of 12.60B BDT in the quarter ending September 30, 2026, with 11.44% growth. This brings the company's total for the last twelve months to 47.49B, up 7.86% year-over-year. In the fiscal year ending June 30, 2026, Renata had annual revenue of 46.20B with 7.71% growth. That makes Renata the 13,003rd largest company in the world by revenue and 16th in Bangladesh.
Revenue (ttm)
47.49B
Revenue Growth
+7.86%
P/S Ratio
1.02
Revenue / Employee
5.47M
Employees
8,681
Market Cap
48.68B
Revenue by Geography
- Bangladesh 43.46B 94.1%
- Export 2.29B 5.0%
- Ireland 436.99M 0.9%
- United Kingdom 16.97M 0.0%
Fiscal year ended Jun 30, 2026 See the full Renata breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2026 | 46.20B | 3.31B | 7.71% |
| Jun 30, 2025 | 42.89B | 5.18B | 13.74% |
| Jun 30, 2024 | 37.71B | 4.74B | 14.37% |
| Jun 30, 2023 | 32.97B | 1.90B | 6.12% |
| Jun 30, 2022 | 31.07B | 1.10B | 3.67% |
| Jun 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Square Pharmaceuticals PLC. | 83.53B |
| Beximco Pharmaceuticals PLC. | 56.27B |
| The ACME Laboratories | 41.60B |
| Beacon Pharmaceuticals | 16.43B |
| The IBN SINA Pharmaceutical Industry | 13.90B |
| Navana Pharmaceuticals | 10.57B |
| Unilever Consumer Care | 3.29B |
| Techno Drugs | 3.10B |